Pfizer (PFE) just unveiled an announcement.
To incentivize and retain key employees, a company has revised its long-term incentive plans by extending the terms and vesting periods for Total Shareholder Return Units (TSRUs) and Performance Share Awards (PSAs) granted in 2022 and 2023. These adjustments enable participants to align their compensation with the company’s long-term shareholder return, with the possibility of extending the settlement period for TSRUs by two years and modifying the PSAs’ performance period to measure over a longer span. The changes, made in response to the pandemic’s impact on the business and stock price, are designed to motivate employees to focus on stock price recovery and maintain their interests in sync with those of the shareholders.
Learn more about PFE stock on TipRanks’ Stock Analysis page.
